Understanding HIV Drug Resistance: Causes, Consequences & Prevention
What Is HIV Drug Resistance?
HIV drug resistance occurs when the virus acquires genetic mutations that reduce or eliminate the effectiveness of one or more antiretroviral drugs. Because HIV replicates rapidly (~1010 virions/day) with an error-prone reverse transcriptase (no proofreading), mutations arise constantly. Under drug pressure, resistant variants are selected and can become dominant.
Causes
- Incomplete viral suppression: Suboptimal drug levels (poor adherence, malabsorption, drug interactions) allow ongoing replication under selective pressure.
- Subtherapeutic drug levels: Missed doses, treatment interruptions, incorrect dosing, vomiting/diarrhea affecting absorption.
- Transmitted resistance: Acquiring an already-resistant strain from a partner (prevalence 10–15% in some regions).
- Sequential monotherapy/functional monotherapy: Adding a single drug to a failing regimen; using drugs with low genetic barriers alone.
- Drug interactions: Inducers (rifampin, certain antiseizure meds, St. John's wort) lowering ARV levels.
- Counterfeit/substandard medications: Inadequate active ingredient.
Consequences
- Virologic failure: Viral load rebound (>200 copies/mL confirmed).
- Loss of future treatment options: Cross-resistance within classes limits future regimens.
- Clinical progression: CD4 decline, opportunistic infections, AIDS-defining illnesses.
- Increased morbidity, mortality, and healthcare costs.
- Transmission of resistant virus: Perpetuates resistance in the community.
Prevention
- Adherence is paramount: Take every dose as prescribed. Use pill boxes, alarms, apps, pharmacy synchronization.
- Baseline resistance testing: Genotypic assay before starting ART (or switching) to guide regimen selection.
- Use high-barrier regimens: INSTI-based (DTG, BIC) or boosted PI (DRV/r) + 2 NRTIs.
- Monitor viral load regularly: Detect failure early (viral load >200 copies/mL triggers resistance testing).
- Avoid treatment interruptions: If stopping is necessary, stop all drugs simultaneously (with clinician guidance).
- Manage drug interactions: Review all medications/supplements at every visit.
- Address adherence barriers: Mental health, substance use, housing, stigma, cost, side effects—treat the whole person.
If Resistance Develops
Resistance testing (genotypic ± phenotypic) guides construction of a new active regimen—typically including at least 2, preferably 3, fully active drugs from different classes. Newer agents (lenacapavir, fostemsavir, ibalizumab) provide options for multi-drug resistant HIV. Close adherence to the new regimen is critical to prevent further resistance.
HIV & AIDS - Related Articles
- Understanding HIV Stage 2: Asymptomatic Phase After 6 Months
- HIV to AIDS Timeline: Why You Can't Know in a Week
- Supporting a Loved One with HIV/AIDS: Compassionate Care Guide
- Stage 2 HIV Symptoms: What to Expect in the Chronic Phase
- Understanding AIDS-Related Conditions: Symptoms and Management
- HIV Risk from Shared Drinks with an Open Cut: Evidence-Based Assessment
- Can You Get HIV from Ice Cream? The Science of Foodborne Transmission
